Report an error

Spotted something inaccurate in “Dual Immunotherapy Cuts Bladder Cancer Recurrence Risk by 60%”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.